Leonid Timashev
Stock Analyst at RBC Capital
(3.38)
# 1,007
Out of 4,989 analysts
107
Total ratings
52.58%
Success rate
2.79%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Maintains: Outperform | $36 → $38 | $25.93 | +46.55% | 2 | Sep 9, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $145 → $151 | $129.40 | +16.69% | 1 | Aug 28, 2025 | |
| XNCR Xencor | Maintains: Outperform | $32 → $15 | $10.32 | +45.35% | 1 | Aug 21, 2025 | |
| INSM Insmed | Maintains: Outperform | $120 → $138 | $145.38 | -5.08% | 5 | Aug 13, 2025 | |
| LEGN Legend Biotech | Maintains: Outperform | $75 → $77 | $32.93 | +133.83% | 13 | Aug 12, 2025 | |
| VSTM Verastem | Maintains: Outperform | $12 → $13 | $9.19 | +41.46% | 2 | Aug 8, 2025 | |
| NUVB Nuvation Bio | Maintains: Outperform | $6 → $7 | $3.22 | +117.39% | 2 | Aug 8, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Outperform | $48 → $49 | $15.09 | +224.72% | 14 | Aug 8, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Outperform | $38 → $39 | $26.67 | +46.23% | 7 | Aug 7, 2025 | |
| ONC BeOne Medicines AG | Maintains: Outperform | $349 → $364 | $329.07 | +10.61% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $184 → $189 | $118.19 | +59.91% | 13 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $40 → $42 | $27.75 | +51.35% | 3 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $50 → $45 | $39.81 | +13.04% | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $25 | $7.09 | +252.61% | 1 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $53 | $36.70 | +44.41% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $13 → $17 | $11.44 | +48.60% | 1 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $5 | $3.38 | +47.93% | 1 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $16 | $3.17 | +404.73% | 1 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $54 → $21 | $14.16 | +48.31% | 12 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $82 → $80 | $48.55 | +64.78% | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $2.19 | +265.30% | 6 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.55 | +93.55% | 1 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $84.54 | -17.20% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $18 | $5.04 | +257.14% | 4 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $4 | $6.02 | -33.55% | 8 | Aug 6, 2024 |
IDEAYA Biosciences
Sep 9, 2025
Maintains: Outperform
Price Target: $36 → $38
Current: $25.93
Upside: +46.55%
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Outperform
Price Target: $145 → $151
Current: $129.40
Upside: +16.69%
Xencor
Aug 21, 2025
Maintains: Outperform
Price Target: $32 → $15
Current: $10.32
Upside: +45.35%
Insmed
Aug 13, 2025
Maintains: Outperform
Price Target: $120 → $138
Current: $145.38
Upside: -5.08%
Legend Biotech
Aug 12, 2025
Maintains: Outperform
Price Target: $75 → $77
Current: $32.93
Upside: +133.83%
Verastem
Aug 8, 2025
Maintains: Outperform
Price Target: $12 → $13
Current: $9.19
Upside: +41.46%
Nuvation Bio
Aug 8, 2025
Maintains: Outperform
Price Target: $6 → $7
Current: $3.22
Upside: +117.39%
Edgewise Therapeutics
Aug 8, 2025
Maintains: Outperform
Price Target: $48 → $49
Current: $15.09
Upside: +224.72%
NewAmsterdam Pharma Company
Aug 7, 2025
Maintains: Outperform
Price Target: $38 → $39
Current: $26.67
Upside: +46.23%
BeOne Medicines AG
Aug 7, 2025
Maintains: Outperform
Price Target: $349 → $364
Current: $329.07
Upside: +10.61%
Aug 5, 2025
Maintains: Outperform
Price Target: $184 → $189
Current: $118.19
Upside: +59.91%
Jul 30, 2025
Maintains: Sector Perform
Price Target: $40 → $42
Current: $27.75
Upside: +51.35%
Jul 29, 2025
Maintains: Sector Perform
Price Target: $50 → $45
Current: $39.81
Upside: +13.04%
Jul 17, 2025
Maintains: Outperform
Price Target: $32 → $25
Current: $7.09
Upside: +252.61%
Jul 16, 2025
Maintains: Outperform
Price Target: $68 → $53
Current: $36.70
Upside: +44.41%
Jun 20, 2025
Reiterates: Outperform
Price Target: $13 → $17
Current: $11.44
Upside: +48.60%
Jun 20, 2025
Maintains: Outperform
Price Target: $8 → $5
Current: $3.38
Upside: +47.93%
Jun 3, 2025
Maintains: Outperform
Price Target: $15 → $16
Current: $3.17
Upside: +404.73%
May 19, 2025
Downgrades: Sector Perform
Price Target: $54 → $21
Current: $14.16
Upside: +48.31%
May 7, 2025
Maintains: Outperform
Price Target: $82 → $80
Current: $48.55
Upside: +64.78%
Mar 19, 2025
Reiterates: Outperform
Price Target: $8
Current: $2.19
Upside: +265.30%
Mar 19, 2025
Maintains: Buy
Price Target: $3
Current: $1.55
Upside: +93.55%
Jan 23, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $84.54
Upside: -17.20%
Jan 15, 2025
Reiterates: Outperform
Price Target: $18
Current: $5.04
Upside: +257.14%
Aug 6, 2024
Reiterates: Sector Perform
Price Target: $4
Current: $6.02
Upside: -33.55%